For: | Ekinci O, Baran B, Ormeci AC, Soyer OM, Gokturk S, Evirgen S, Poyanli A, Gulluoglu M, Akyuz F, Karaca C, Demir K, Besisik F, Kaymakoglu S. Current state and clinical outcome in Turkish patients with hepatocellular carcinoma. World J Hepatol 2018; 10(1): 51-61 [PMID: 29399278 DOI: 10.4254/wjh.v10.i1.51] |
---|---|
URL: | https://www.wjgnet.com/1948-5182/full/v10/i1/51.htm |
Number | Citing Articles |
1 |
|
2 |
Busra Tozduman, Gul Ergor. The fraction of cancer attributable to modifiable risk factors in Turkey in 2018. International Journal of Cancer 2024; doi: 10.1002/ijc.35317
|
3 |
Sheikh Omar Bittaye, Abubacarr Kambi, Momodou A. I. Tekanyi, Saydiba Tamba, Lamin Sanneh, Momodou Musa Sisawo, Abdoulie Jatta, Gibril Fatty, Adam Jeng, Momodou Salieu Jallow, Ousman Leigh, Ramou Njie. Clinical manifestation, staging and prognosis of hepatocellular carcinoma in Gambian patients. BMC Gastroenterology 2023; 23(1) doi: 10.1186/s12876-023-02952-8
|